BRIEF published on 12/09/2025 at 18:35, 4 months 29 days ago Theraclion Submits Sonovein to FDA After Year of Key Achievements FDA Submission Clinical Evidence SONOVEIN Regulatory Achievements Varicose Vein Treatment
BRIEF published on 12/09/2025 at 18:35, 4 months 29 days ago Theraclion submits Sonovein to the FDA after significant progress FDA Theraclion SONOVEIN Varicose Veins HIFU
BRIEF published on 12/09/2025 at 18:35, 4 months 29 days ago Theraclion soumet Sonovein à la FDA après d'importants progrès FDA Theraclion SONOVEIN Varices HIFU
BRIEF published on 12/09/2025 at 18:35, 4 months 29 days ago Theraclion soumet le Sonovein à la FDA après une année de succès clés Soumission À La FDA SONOVEIN Réalisations Réglementaires Traitement Des Varices Preuves Cliniques
PRESS RELEASE published on 12/09/2025 at 18:30, 4 months 29 days ago Informations privilégiées / Autres communiqués Theraclion annonce la soumission de Sonovein à la FDA après une année de progrès réglementaires et cliniques, avec des résultats encourageants et des avancées significatives en Europe et en Chine FDA Theraclion SONOVEIN Varices HIFU
PRESS RELEASE published on 12/09/2025 at 18:30, 4 months 29 days ago Inside Information / Other news releases Theraclion announces FDA submission of Sonovein following a year of regulatory and clinical achievements. Key milestones in Europe and China also reached Clinical Milestones FDA Submission Theraclion SONOVEIN Regulatory Achievements
BRIEF published on 10/29/2025 at 18:35, 6 months 9 days ago Theraclion Announces 2025 Half-Year Financial Results and Strategic Progress Financial Results Revenue Growth Market Expansion U.S. Study Certification Progress
BRIEF published on 10/29/2025 at 18:35, 6 months 9 days ago Theraclion annonce ses résultats financiers et ses progrès stratégiques pour le premier semestre 2025. Résultats Financiers Croissance Des Revenus Expansion Du Marché Étude Américaine Progression De La Certification
PRESS RELEASE published on 10/29/2025 at 18:30, 6 months 9 days ago Inside Information / News release on accounts, results Theraclion reports successful pivotal study, CE certification, GB 9706.1-2020 certification; 89% revenue increase and 23% operating loss reduction in 2025 half-year results Revenue Increase Operating Loss Reduction CE Certification Pivotal Study Theraclion
PRESS RELEASE published on 10/29/2025 at 18:30, 6 months 9 days ago Informations privilégiées / Communiqué sur comptes, résultats Theraclion annonce ses récentes avancées majeures et ses résultats financiers du premier semestre 2025, confirmant une forte efficacité de sa plateforme robotique HIFU pour le traitement des varices Résultats Financiers Theraclion Varices Avancées Majeures HIFU
Published on 05/08/2026 at 15:00, 14 minutes ago Jaguar Health Regains Compliance with Nasdaq's Publicly Held Shares Requirement and Receives Additional Extension, Until May 18, 2026, to Demonstrate Compliance with Nasdaq's Bid Price Rule
Published on 05/08/2026 at 14:55, 19 minutes ago Nepra Foods Inc. to Present at the 16th Annual LD Micro Invitational
Published on 05/08/2026 at 14:30, 44 minutes ago Unusual Machines Hosts Live Drone Ecosystem Demonstrations at XPONENTIAL 2026
Published on 05/08/2026 at 14:00, 1 hour 14 minutes ago BlackBerry Announces Renewal of Normal Course Issuer Bid Share Buyback Program
Published on 05/08/2026 at 14:00, 1 hour 14 minutes ago Loop Industries to Host Fourth Quarter 2025 Earnings Conference Call
Published on 05/08/2026 at 15:08, 6 minutes ago Siltronic AG's Annual General Meeting approves all agenda items by a clear majority
Published on 05/08/2026 at 13:53, 1 hour 21 minutes ago Fuller, Smith & Turner PLC: Transaction in own shares
Published on 05/08/2026 at 13:35, 1 hour 39 minutes ago DeFi Technologies Announces Partnership with OMFIF's Digital Monetary Institute and Confirms Participation at the Digital Money Summit 2026 in London
Published on 05/08/2026 at 13:05, 2 hours 9 minutes ago Philadelphia Soccer 2026 Opens Media Credentialing and Fan Registration for FIFA Fan Festival™ Philadelphia
Published on 05/07/2026 at 19:15, 19 hours 59 minutes ago 2026 Annual General Meeting: approval of all resolutions submitted to the Meeting
Published on 05/07/2026 at 19:15, 19 hours 59 minutes ago Assemblée Générale annuelle 2026 : approbation de l’ensemble des résolutions soumises au vote
Published on 05/07/2026 at 19:06, 20 hours 8 minutes ago Disclosure of Share Capital and Voting Rights as of April 30, 2026
Published on 05/07/2026 at 19:06, 20 hours 8 minutes ago Déclaration du nombre d’actions et droits de vote au 30 avril 2026
Published on 05/07/2026 at 19:00, 20 hours 14 minutes ago ALTAREIT - INFORMATION RELATIVE AU NOMBRE TOTAL DE DROITS DE VOTE ET D’ACTIONS COMPOSANT LE CAPITAL SOCIAL
